Arbutus Biopharma (ABUS) Payables (2010 - 2026)
Arbutus Biopharma's Payables was $2.85 million in Q2 2026, down 36.8% from $4.51 million a year earlier and down 36.3% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Payables at Arbutus Biopharma came in at $5.46 million, down 27.8% from FY2024.
- Payables has now declined for three consecutive years, with a five-year compound annual growth rate of -9.8% (FY2020 to FY2025).
- In earlier years, Payables was $7.56 million in FY2024 (-26.4%), $10.27 million in FY2023 (-35.9%), $16.03 million in FY2022 (+47.9%) and $10.84 million in FY2021 (+18.4%).
- The Q2 2026 figure marks the lowest quarterly Payables in data going back to Q4 2010.
- Compared with a year earlier, Payables has declined for five straight quarters, with an average decline of 28.5% over the last eight quarters.
- The best year-over-year quarter for Payables over five years was Q2 2022 (growth of 49.4%); the worst was Q1 2026 (a decline of 63.1%).
- Per Business Quant data, ABUS's Payables in the three quarters before Q2 2026 was $4.47 million (Q1 2026), $5.46 million (Q4 2025) and $4.65 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Arbutus Biopharma | 960.50 Mn | 587.48 Mn | - | 2.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.85 Mn |
| Mar 31, 2026 | 4.47 Mn |
| Dec 31, 2025 | 5.46 Mn |
| Sep 30, 2025 | 4.65 Mn |
| Jun 30, 2025 | 4.51 Mn |
| Mar 31, 2025 | 12.11 Mn |
| Dec 31, 2024 | 7.56 Mn |
| Sep 30, 2024 | 7.54 Mn |
| Jun 30, 2024 | 11.11 Mn |
| Mar 31, 2024 | 8.25 Mn |
| Dec 31, 2023 | 10.27 Mn |
| Sep 30, 2023 | 9.81 Mn |
| Jun 30, 2023 | 8.81 Mn |
| Mar 31, 2023 | 9.65 Mn |
| Dec 31, 2022 | 16.03 Mn |
| Sep 30, 2022 | 12.27 Mn |
| Jun 30, 2022 | 12.47 Mn |
| Mar 31, 2022 | 8.72 Mn |
| Dec 31, 2021 | 10.84 Mn |
| Sep 30, 2021 | 9.73 Mn |
API Access
Arbutus Biopharma Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();